Pediatric leadership silence on FDA ADHD recall
“The FDA has issued a nationwide recall of lisdexamfetamine capsules.”
That sentence in Newsweek magazine should have triggered alerts, guidance, and coordinated response. Instead, the silence from pediatric leadership has been deafening. Newsweek turned to the FDA and the American Academy of Family Physicians. Where are the leadership of the American Academy of Pediatrics (AAP) and the Society for Developmental and Behavioral Pediatrics? Silent. Why?
The recall that should have sparked action
In …











![Sibling advice for surviving the medical school marathon [PODCAST]](https://kevinmd.com/wp-content/uploads/Design-1-190x100.jpg)